Determination of N-Methylpyrrolidine in Cefepime with Nonsuppressed Conductivity Detection

Importance of Determining N-Methylpyrrolidine in Cefepime

The degradation of the fourth-generation cephalosporin cefepime generates N-methylpyrrolidine (NMP), which reduces antibiotic potency and may pose toxicity risks. Accurate quantification of NMP is critical for pharmaceutical quality control and regulatory compliance, ensuring patient safety and drug efficacy.

Aims and Study Overview

This work presents a rapid, reliable method for measuring NMP in cefepime hydrochloride and simulated injection formulations using cation-exchange chromatography with nonsuppressed conductivity detection. The method aligns with United States Pharmacopeia (USP) monograph requirements while improving sample throughput and simplifying eluent preparation.

Methodology and Instrumentation Used

Chromatographic separation was performed on a Dionex ICS-2100 system equipped with:

• IonPac SCG1 guard column (4×50 mm) and SCS1 analytical column (4×250 mm) with carboxylic acid functionality
• Single isocratic pump, vacuum degasser, column heater, and nonsuppressed conductivity detector at 40 °C
• Autosampler cooled to 4–6 °C and Chromeleon CDS software

Eluent consisted of 10 mM nitric acid with 5 % acetonitrile at 1.00 mL/min and 30 °C. Standards and samples were prepared in 2 mM nitric acid. NMP stock solutions (1000 µg/mL) were gravimetrically diluted, and cefepime matrices (5 mg/mL) were spiked for recovery and precision assessments.

Main Results and Discussion

Chromatograms showed baseline-resolved peaks for common cations, arginine, NMP (retention ~9.7 min), and cefepime. Key performance metrics included:

• Resolution (Rs) between arginine and NMP >8
• Peak asymmetry of NMP =1.1 and theoretical plates >15 000
• Limit of detection (LOD) =0.5 µg/mL and limit of quantification (LOQ) =1.6 µg/mL, corresponding to 0.01 % and 0.032 % in 5 mg/mL cefepime
• Linearity over 5–100 µg/mL NMP (r2 =0.9996)
• Spike recovery of 15 µg/mL NMP in cefepime =99 ± 1.0 %
• Repeatability for NMP standard: retention time RSD 0.02 %, peak area RSD 0.4 %; for cefepime samples: retention time RSD ≤0.13 %, peak area RSD ≤1.6 %

Minor sample instability was observed over 6 h in the autosampler (2.7–3.9 % NMP increase), highlighting the advantage of faster methods.

Benefits and Practical Applications of the Method

The nonsuppressed conductivity approach meets USP procedure limits for organic impurities while:

• Reducing eluent complexity by eliminating suppressor maintenance
• Increasing sample throughput to approximately 60 min per analysis
• Maintaining sensitivity adequate for regulatory specifications

This method is suitable for routine quality control of cefepime hydrochloride and injectable formulations.

Future Trends and Potential Uses

Advancements may include automation of sample handling to minimize degradation, coupling with mass detection for specificity, miniaturized column formats to further reduce run times, and adaptation to other beta-lactam antibiotics. Integration into high-throughput pharmaceutical QC laboratories will enhance compliance and efficiency.

Conclusion

The described nonsuppressed conductivity chromatography method provides a robust, accurate, and precise determination of N-methylpyrrolidine in cefepime products. It fulfills USP requirements, simplifies eluent preparation, and offers improved laboratory productivity.

Reference

1. Sader HS, Fritsche TR, Jones RN. Potency and Spectrum Trends for Cefepime Tested Against 65 746 Clinical Isolates: SENTRY Program. Diagn Microbiol Infect Dis. 2005;52(3):265–273.
2. FDA. Maxipime (Cefepime Hydrochloride) for Injection Labeling. 2010.
3. Sprauten PF, Beringer PM, Louie SG, Synold TW, Gill MA. Stability and Antibacterial Activity of Cefepime During Continuous Infusion. Antimicrob Agents Chemother. 2003;47(6):1991–1994.
4. Forgue ST, Kari P, Barbhaiya R. N-Oxidation of N-Methylpyrrolidine Released In Vivo from Cefepime. Drug Metab Dispos. 1987;15(6):808–815.
5. Dionex Corp. Determination of Cefepime and Related Substances by HPLC-UV. Application Note 205; 2008.
6. Dionex Corp. Determination of NMP in Cefepime by RFIC with Suppressed Detection. Application Note 199; 2008.
7. USP. Validation of Compendial Methods <1225>. USP 33–NF 28; 2010.